Biocartis Group NV
XBRU:BCART
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Huafon Chemical Co Ltd
SZSE:002064
|
CN |
Biocartis Group NV
Other
Biocartis Group NV
Other Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Biocartis Group NV
XBRU:BCART
|
Other
-€56k
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
Nyxoah SA
XBRU:NYXH
|
Other
-€4.1m
|
CAGR 3-Years
-121%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Ion Beam Applications SA
XBRU:IBAB
|
Other
€1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Sequana Medical NV
XBRU:SEQUA
|
Other
-€184.1k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
Biocartis Group NV
Glance View
Biocartis Group NV which engages in the development of oncology molecular diagnostic solutions. The company is headquartered in Malines (Mechelen), Antwerpen and currently employs 619 full-time employees. The company went IPO on 2015-04-27. The group has the Idylla system to deliver results within a period of between 35 to 150 minutes.
See Also
What is Biocartis Group NV's Other?
Other
-56k
EUR
Based on the financial report for Jun 30, 2023, Biocartis Group NV's Other amounts to -56k EUR.
What is Biocartis Group NV's Other growth rate?
Other CAGR 5Y
-5%
Over the last year, the Other growth was 46%. The average annual Other growth rates for Biocartis Group NV have been -12% over the past three years , -5% over the past five years .
